Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era

被引:18
作者
Shiba, N
Chan, MCY
Valantine, HA
Gao, SZ
Robbins, RC
Hunt, SA
机构
[1] Stanford Univ, Med Ctr, Div Cardiovasc Med, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, Dept Cardiothorac Surg, Stanford, CA 94305 USA
关键词
D O I
10.1016/S1053-2498(02)01192-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Long-term survival after heart transplantation is common in the cyclosporine era. However, there are few data documenting pre-transplant/perioperative factors predictive of truly long-term survival (>10 years). The purpose of this study is to identify factors associated with 10-year survival after heart transplantation. Methods: Our study population included 197 adults who survived >6 months and died <10 years after heart transplant (medium-term group) and 140 adults who survived >10 years after heart transplant (long-term group) between December 1980 and May 2001. A comparison was done between the two groups and We used multivariate analysis to identify which factors predicted 10-year survival. Results: The long-term group had younger recipient and donor age, lower recipient body mass index at transplant, shorter waiting time and lower percentages of ischemic etiology/male recipient/non-white recipient. Kaplan-Meier plots of freedom from graft coronary artery disease and malignancy showed later onset patterns in the long-term group compared with the medium-term group. Multivariate analysis showed that white recipient, younger recipient and lower recipient body mass index at heart transplant were factors significantly associated with 10-year survival. Conclusions: Several pre-transplant/peri-operative factors were associated with survival beyond 10 years after heart transplantation. Stratified/tailored strategies based on these factors may be helpful to attain longer-term survival of recipients with higher risks.
引用
收藏
页码:1098 / 1106
页数:9
相关论文
共 35 条
[21]  
Lietz K, 2001, CIRCULATION, V104, pI177
[22]   Risk factors for death after heart transplantation: Does a single-center experience correlate with multicenter registries? [J].
McCarthy, JF ;
McCarthy, PM ;
Massad, MG ;
Cook, DJ ;
Smedira, NG ;
Kasirajan, V ;
Goormastic, M ;
Hoercher, K ;
Young, JB .
ANNALS OF THORACIC SURGERY, 1998, 65 (06) :1574-1578
[23]  
MCCARTHY PM, 1996, STANFORD MANUAL CARD, P31
[24]   Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation [J].
Mehra, MR ;
Uber, PA ;
Scott, RL ;
Prasad, AK ;
Park, MH .
TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) :1613-1614
[25]  
Mills RM, 1997, J HEART LUNG TRANSPL, V16, P813
[26]   Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center [J].
Montoya, JG ;
Giraldo, LF ;
Efron, B ;
Stinson, EB ;
Gamberg, P ;
Hung, S ;
Giannetti, N ;
Miller, J ;
Remington, JS .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (05) :629-640
[27]   The role of gender in heart transplantation [J].
Prendergast, TW ;
Furukawa, S ;
Beyer, AJ ;
Browne, BJ ;
Eisen, HJ ;
Jeevanandam, V .
ANNALS OF THORACIC SURGERY, 1998, 65 (01) :88-94
[28]   AGE-ASSOCIATED DECLINE IN CARDIAC ALLOGRAFT-REJECTION [J].
RENLUND, DG ;
GILBERT, EM ;
OCONNELL, JB ;
GAY, WA ;
JONES, KW ;
BURTON, NA ;
DOTY, DB ;
KARWANDE, SV ;
DEWITT, CW ;
MENLOVE, RL ;
HERRICK, CM ;
BRISTOW, MR .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (03) :391-398
[29]  
Rickenbacher PR, 1997, EUR HEART J, V18, P870
[30]   Coronary artery intimal thickening in the transplanted heart - An in vivo intracoronary ultrasound study of immunologic and metabolic risk factors [J].
Rickenbacher, PR ;
Kemna, MS ;
Pinto, FJ ;
Hunt, SA ;
Alderman, EL ;
Schroeder, JS ;
Stinson, EB ;
Popp, RL ;
Chen, I ;
Reaven, G ;
Valantine, HA .
TRANSPLANTATION, 1996, 61 (01) :46-53